Literature DB >> 19302429

Assessing the blood pressure-lowering efficacy of antihypertensive medications: which blood pressures should we use?

Matthew R Weir1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19302429      PMCID： PMC8673242          DOI： 10.1111/j.1751-7176.2009.00087.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN： 1524-6175            Impact factor:   3.738


× No keyword cloud information.
  9 in total

1.  Assessment of antihypertensive activity in the regulatory setting.

Authors:  M G Myers; R J Lipicky
Journal:  Blood Press Monit       Date:  2001-12       Impact factor: 1.444

2.  Should the target for blood pressure control specify both a systolic and a diastolic component?

Authors:  Christopher J Hebert; Ganesh Shidham; Lee A Hebert
Journal:  Curr Hypertens Rep       Date:  2005-10       Impact factor: 5.369

3.  Hypertension treatment: how important is consistency of effect?

Authors:  Domenic A Sica
Journal:  Hypertension       Date:  2007-07-02       Impact factor: 10.190

4.  2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

Authors:  Giuseppe Mancia; Guy De Backer; Anna Dominiczak; Renata Cifkova; Robert Fagard; Giuseppe Germano; Guido Grassi; Anthony M Heagerty; Sverre E Kjeldsen; Stephane Laurent; Krzysztof Narkiewicz; Luis Ruilope; Andrzej Rynkiewicz; Roland E Schmieder; Harry A J Struijker Boudier; Alberto Zanchetti; Alec Vahanian; John Camm; Raffaele De Caterina; Veronica Dean; Kenneth Dickstein; Gerasimos Filippatos; Christian Funck-Brentano; Irene Hellemans; Steen Dalby Kristensen; Keith McGregor; Udo Sechtem; Sigmund Silber; Michal Tendera; Petr Widimsky; José Luis Zamorano; Serap Erdine; Wolfgang Kiowski; Enrico Agabiti-Rosei; Ettore Ambrosioni; Lars H Lindholm; Margus Viigimaa; Stamatis Adamopoulos; Enrico Agabiti-Rosei; Ettore Ambrosioni; Vicente Bertomeu; Denis Clement; Serap Erdine; Csaba Farsang; Dan Gaita; Gregory Lip; Jean-Michel Mallion; Athanasios J Manolis; Peter M Nilsson; Eoin O'Brien; Piotr Ponikowski; Josep Redon; Frank Ruschitzka; Juan Tamargo; Pieter van Zwieten; Bernard Waeber; Bryan Williams
Journal:  J Hypertens       Date:  2007-06       Impact factor: 4.844

5.  Comparison of valsartan/hydrochlorothiazide combination therapy at doses up to 320/25 mg versus monotherapy: a double-blind, placebo-controlled study followed by long-term combination therapy in hypertensive adults.

Authors:  James L Pool; Robert Glazer; Myron Weinberger; Roxanne Alvarado; Jie Huang; Alan Graff
Journal:  Clin Ther       Date:  2007-01       Impact factor: 3.393

6.  Differential control of systolic and diastolic blood pressure : factors associated with lack of blood pressure control in the community.

Authors:  D M Lloyd-Jones; J C Evans; M G Larson; C J O'Donnell; E J Roccella; D Levy
Journal:  Hypertension       Date:  2000-10       Impact factor: 10.190

7.  Stroke and coronary heart disease in treated hypertension -- a prospective cohort study over three decades.

Authors:  T Almgren; B Persson; L Wilhelmsen; A Rosengren; O K Andersson
Journal:  J Intern Med       Date:  2005-06       Impact factor: 8.989

8.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  Hypertension       Date:  2003-12-01       Impact factor: 10.190

9.  Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies.

Authors:  Sarah Lewington; Robert Clarke; Nawab Qizilbash; Richard Peto; Rory Collins
Journal:  Lancet       Date:  2002-12-14       Impact factor: 79.321
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.